26th Annual Summer Seminars: Essential Psychopharmacology, 2015
Nassi Ghaemi, MD, MPH
An updated review of clinical psychopharmacology will be presented. Neurobiology and pharmacokinetics and pharmacodynamics will be incorporated throughout the course, as well as careful analyses of clinical trials and their results. Specific clinical conditions examined will include schizophrenia, bipolar and depressive illnesses, anxiety conditions, ADHD, and personality disorders. Treatment in adults, including the elderly, and children will be discussed separately. The relationship of treatments to different diagnostic definitions of major psychiatric conditions will be examined in detail, including current and past DSM-defined categories, as well as other diagnostic constructs, such as spectrum concepts. Educational formats will include lectures, Q&A and case based group discussions.
- Describe the tenets of psychotropic drug treatment, with particular emphasis on recent advances and practical prescribing information;
- Evaluate the basic tenets of the pharmacology of the major psychotropic drug classes;
- Review basic neurobiology as it relates to clinical practice with drug treatment;
- Analyze the basic pharmacodynamics and pharmacokinetics of major drug classes;
- Review the designs of maintenance trials for psychotropic drugs, and implications for interpretation of long-term efficacy or lack thereof;
- Implement clinical practice with antipsychotics based on the best randomized clinical trials for schizophrenia, bipolar disorder and depression;
- Utilize mood stabilizers based on the best randomized clinical trials for bipolar disorder and depression;
- Prescribe antidepressants based on the best randomized clinical trials for depression and bipolar disorder;
- Make dosage adjustments in the elderly and children for age, drug interactions,
and sensitivity to side effects;
- Determine the mechanisms, efficacy, and side effects of benzodiazepines for anxiety conditions and insomnia;
- Describe the mechanisms, risks, and benefits of amphetamines for ADHD in children and adults;
- Evaluate the inter play between pharmacologic and non-pharmacologic treatments;
- Review different diagnostic definitions of mood illness, including DSM and non-DSM approaches.
Warning: Invalid argument supplied for foreach() in /nfs/c10/h13/mnt/150145/domains/continuingeducationprogram.org/html/wp-content/themes/bidmc/single-courses.php on line 110
Registration: 8:30 am
Seminar Format: Monday – Friday: 9:00 am – 12:15 pm
Beth Israel Deaconess Department of Psychiatry Foundation, Inc./Contact Hours: 15
PHYSICIANS: The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Harvard Medical School designates this live activity for a maximum of 15 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Weeklong Seminar: A maximum of 15 AMA PRA Category 1 Credits™
Weekend Seminar: A maximum of 10 AMA PRA Category 1 Credits™
THE ROYAL COLLEGE OF PHYSICIANS AND SURGEONS OF CANADA recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.
AMA PRA Category 1 Credits™ claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credits™ can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the EUROPEAN CONTINUOUS MEDICAL EDUCATION CREDITS(ECMEC©) granted by the UEMS. One AMA PRA Category 1 Credit™ is equivalent to one (1) hour of European EACCME Credit (ECMEC©), therefore up to 15 ECMEC© Credits are available. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
PSYCHOLOGISTS: The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School is approved by the American Psychological Association to offer continuing education for psychologists. The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School maintains responsibility for this program and its content.
COUNSELORS: The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School continuing education is an NBCC Approved Continuing Provider (ACEP) and may offer NBCC approved clock hours for events that meet NBCC requirements. The Week-Long Summer Seminars for a maximum of 15 clock hours and the Weekend Summer Seminars for a maximum of 10 clock hours. The ACEP solely is responsible for all aspects of the program.
SOCIAL WORKERS: For information on the status of the application to the Massachusetts Chapter of the National Association of Social Workers, please call 617-754-1265 or email: email@example.com.
NURSES: The following program have been approved by the Massachusetts Association of Registered Nurses Inc. an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Nassir Ghaemi, MD, MPH is Professor of Psychiatry, Tufts University School of Medicine and Lecturer on Psychiatry, Harvard Medical School. Dr. Ghaemi is also the recipient of a Master of Arts Degree in Philosophy and a Master of Public Health in the Clinical Effectiveness Program of Harvard School of Public Health. He is Director, Mood Disorders Program, Tufts Medical Center. Dr. Ghaemi has authored over 100 scientific articles or book chapters and serves on the editorial boards of numerous journals. He is the author of 4 books including, Mood Disorders: A Practical Guide. His most recent book (a New York Times Best Seller) is, A First Rate Madness: Uncovering the Links between Leadership and Mental Illness.